Table 2.
Prevalence of carbapenem resistance among Gram-negative bacteria isolated from clinical samples in selected national and international surveillance networks
| Surveillance network | CHINET | CDC/NHSN | SENTRY | SENTRY | SENTRY | EB-2 | EARS-Net | SPIADI | SPIADI |
|---|---|---|---|---|---|---|---|---|---|
| Geographical area | China | USA | USA | Western Europe | Eastern Europe | Worldwide | Europe | France | France |
| Sample collection, period | 2016 | 2015–2017 | 2016–2019 | 2016–2019 | 2016–2019 | 2019–2020 | 2021 | 2021 | 2021 |
| Infection type | HA-BSI | DA-HAI | Pneumonia a | Pneumoniaa | Pneumoniaa | HA-BSI (ICU) | Allb | VAP (ICU) |
HA-CR-BSI |
| References | [20] | [21] | [22] | [22] | [22] | [23] | [8] | [211] | [211] |
|
Enterobacterales Escherichia coli Klebsiella pneumoniae |
– 1.6% 42.9% |
– 0.7% 6.9% |
– 0.5% 4.7% |
– 0.4% 8.7% |
– 0.5% 17.5% |
– 7.4% 37.8% |
– 0.2% 11.7% |
– – – |
0.6% – – |
| Pseudomonas aeruginosa | 24.3% | 20.7% | 25.2% | 23.1% | 51.7% | 33.2% | 18.1% | 20.8% | 9.0% |
| Acinetobacter baumannii | 57.7% | 43.2% | 41.2% | 54.2% | 89.6% | 84.6% | 39.9% | 22.8% | – |
HA: hospital-acquired; BSI: bloodstream infection; DA-HAI: device-associated healthcare-associated infection; ICU: intensive care unit; VAP: ventilator-associated pneumoniae; CR: catheter-related
aCommunity-onset pneumonia requiring hospitalization and hospital-acquired pneumonia (pooled); bcommunity-onset infections and hospital-acquired infections (pooled)